Evidence map›Paper›PMID 33344116›Full record

ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2020

Different Approaches to Develop Nanosensors for Diagnosis of Diseases.

Nina Arndt, Huong D N Tran, Run Zhang, Zhi Ping Xu, Hang T Ta

Abstract readReview
In one paragraph

Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Caging of a Strongly Pairing Fluorescent Thymidine Analog with Soft Nucleophiles.Chemistry (Weinheim an der Bergstrasse, Germany) · 2023
    Article
  11. Review
  12. Review
  13. Different Approaches to Develop Nanosensors for Diagnosis of Diseases.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nina ArndtQueensland Micro- and Nanotechnology Centre Griffith University Brisbane Queensland 4111 Australia.
Huong D N TranQueensland Micro- and Nanotechnology Centre Griffith University Brisbane Queensland 4111 Australia.
Run ZhangAustralian Institute for Bioengineering and Nanotechnology the University of Queensland Brisbane Queensland 4072 Australia.
Zhi Ping XuAustralian Institute for Bioengineering and Nanotechnology the University of Queensland Brisbane Queensland 4072 Australia.
Hang T TaQueensland Micro- and Nanotechnology Centre Griffith University Brisbane Queensland 4111 Australia.ORCID https://orcid.org/0000-0003-1188-0472

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The success of clinical treatments is highly dependent on early detection and much research has been conducted to develop fast, efficient, and precise methods for this reason. Conventional methods relying on nonspecific and targeting probes are being outpaced by so-called nanosensors. Over the last two decades a variety of activatable sensors have been engineered, with a great diversity concerning the operating principle. Therefore, this review delineates the achievements made in the development of nanosensors designed for diagnosis of diseases.

Indexed as

disease diagnosismicrosensorsnanosensors

Identifiers

PMID33344116
PMCPMC7740096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.